Characteristic | primary cohort (n = 296) | validation cohort (n = 146) | p value |  |
---|---|---|---|---|
Age(year) | Â | Â | 0.734 | Â |
 <=65 | 135 | 69 |  |  |
 > 65 | 161 | 77 |  |  |
Gender | Â | Â | 0.348 | Â |
 Male | 186 | 85 |  |  |
 Female | 110 | 61 |  |  |
Tumor grade | Â | Â | 0.452 | Â |
 G1 | 7 | 1 |  |  |
 G2 | 101 | 52 |  |  |
 G3 | 188 | 93 |  |  |
Clinical stage | Â | Â | 0.853 | Â |
 I | 38 | 15 |  |  |
 II | 97 | 49 |  |  |
 III | 130 | 68 |  |  |
 IV | 31 | 14 |  |  |
T classification | Â | Â | 0.9 | Â |
 T1 | 13 | 7 |  |  |
 T2 | 61 | 26 |  |  |
 T3 | 145 | 72 |  |  |
 T4 | 77 | 41 |  |  |
N classification | Â | Â | 0.826 | Â |
 N0 | 90 | 40 |  |  |
 N1 | 80 | 43 |  |  |
 N2 | 64 | 29 |  |  |
 N3 | 62 | 34 |  |  |
M classification | Â | Â | 0.918 | Â |
 M0 | 277 | 137 |  |  |
 M1 | 19 | 9 |  |  |